2023 Press Release | Canady Life Sciences

USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024

by PVA_Admin | Sep 22, 2023 | 2023 Press Release, Press Release

USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024 TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences...

Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”

by PVA_Admin | Aug 2, 2023 | 2023 Press Release, Press Release

Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers” The First Cold Atmospheric Plasma Phase 1 Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer TAKOMA PARK, Md.–(BUSINESS...

USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

by PVA_Admin | Jun 29, 2023 | 2023 Press Release, Press Release

USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™ TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC, announced today it has...

JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors

by PVA_Admin | Jun 15, 2023 | 2023 Press Release, Press Release

JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors TAKOMA PARK, Md.–(BUSINESS WIRE)—June 15, 2023 – The Jerome Canady Research...